Health
CanSinoBIO files application in China for COVID-19 vaccine approval – Devdiscourse
“The efficacy of Ad5-nCoV has met the relevant technical standards laid out by the World Health Organization and relevant standards and requirements set out …by…
CanSino Biologics Inc (CanSinoBIO) said on Wednesday it has filed an application in China for approval of its COVID-19 vaccine to become the country’s third locally developed shot allowed for use by the general public.
While China has yet to approve rival vaccines developed by Western drug makers, it has granted authorization to domestic products that have also gained ground in many developing countries battling a surge in coronavirus infections. CanSinoBIO said interim analysis of data from its…
-
Noosa News24 hours agoCopperString transmission line projected to cost almost $14b amid massive blowout
-
General23 hours agoMyanmar earthquake rescue efforts wind down as death toll hits 3,600
-
Business23 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?
-
Noosa News16 hours agoWatch desert floodwaters gushing towards Lake Eyre